Dec 12, 2016 12:00 pm UTC| Business
Patient focused webinar titled “Stem Cell Transplants for Acute Myeloid Leukemia: What you Need to Know”Webinar to be led by transplant expert, Dr. Patrick Stiff, Director of the Cardinal Bernardin Cancer Center at Loyola...
Dec 12, 2016 12:00 pm UTC| Business
NEW YORK, Dec. 12, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative...
Emergent BioSolutions Receives Health Canada Approval for Botulism Antitoxin
Dec 12, 2016 12:00 pm UTC| Business
GAITHERSBURG, Md., Dec. 12, 2016 -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that Health Canada has approved the company’s New Drug Submission (NDS) for its botulism antitoxin, BAT® [Botulism Antitoxin...
Tautachrome Moves Up To OTCQB; Important Milestone Achieved
Dec 12, 2016 12:00 pm UTC| Business
ORO VALLEY, Ariz., Dec. 12, 2016 -- Tautachrome, Inc. today said it is pleased to announce that it has upgraded from the OTC: Pink to the higher tier OTCQB. The Company's stock will begin trading on the OTCQB today, a...
Akoustis™ Adds New OEM Customer, Purchase Order For High Frequency BAW RF Filters
Dec 12, 2016 12:00 pm UTC| Business
Charlotte, N.C., Dec. 12, 2016 -- Akoustis Technologies, Inc. (OTCQB: AKTS) (“Akoustis” or the “Company”), a manufacturer of patented single-crystal BulkONE™ bulk acoustic wave (BAW) high-band RF filters for mobile and...
Akorn Announces Completion of FDA Re-inspection of Decatur Facility
Dec 12, 2016 12:00 pm UTC| Business
LAKE FOREST, Ill., Dec. 12, 2016 -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) conducted a re-inspection of its Decatur,...
Calithera Biosciences Announces Key Management Changes
Dec 12, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 12, 2016 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, announced that William D. Waddill...